GSK

Money

GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan

Key Takeaways GSK Plc’s U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion…

Read More »
Back to top button